Health Catalyst (HCAT) Tops Q3 EPS by 6c

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $44.59 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• Evommune, Inc. (EVMN) Misses Q2 EPS by 20c